News

Jointly discovered by scientists at Sequella and the National Institute of Allergy and Infectious Diseases (NIAID), SQ109 is currently being investigated in Phase 2 efficacy studies in TB

While MSD brings the scientific excellence of the compound to the partnership, Sun Pharma brings its expertise in the marketing of drugs in the relevant therapeutic areas across

Depakote delayed-release tablets falls under the central nervous system (CNS) therapeutic category as a treatment for the manic episodes associated with bipolar disorder. They are indicated as monotherapy

Mircera Injection Syringe uses epoetin beta (genetical recombination) which is chemically combined with a single molecule of linear methoxy polyethylene glycol (PEG). It has a longer serum half-life

The increase was driven primarily by the continued growth of Tysabri (natalizumab) revenues, which increased 15% to $251m, and Avonex (interferon beta-1a) revenues, which increased 8% to $642m.

Bayer will manufacture the bulk drug substance at its Berkeley, California clinical manufacturing center to support Phase 1 clinical testing planned to commence in 2012. OncoMed Pharma president

Developed by Teikoku Pharma USA, a subsidiary of Teikoku Seiyaku, the Aricept Patch is a weekly transdermal patch intended to provide an alternative formulation for Alzheimer’s patients. Teikoku

The product candidates are currently in early- to mid-stage clinical development for a variety of diseases. They target several novel pathways of disease by inhibiting the activity of

Sage Healthcare Division, which serves more than 400,000 healthcare professionals, including 80,000 physicians in North America, will make its ONC-ATCB certified Sage Intergy Meaningful Use Edition available to